Several studies have shown the upregulation of MMPs, such as MMP2 and MMP9, in ovarian cancer tissues compared to normal or benign ovarian tissues, and their expression levels correlate with clinical stage, tumor invasiveness, and metastatic potential [155,157,160,161]. Here, MMP9 is linked to ovarian carcinoma.